You are here

Beijing suspends Ali Health-run online drug monitoring platform

Authorities drafting amendments to rules monitoring pharmaceutical sales
Tuesday, February 23, 2016 - 05:50


CHINA'S food and drugs regulatory body said it had suspended its electronic drug monitoring system, a platform operated by Alibaba Health Information Technology Ltd, while it drafts amendments to regulations monitoring pharmaceutical sales.

The China Food and Drug

Market voices on:

Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at

Powered by GET.comGetCom